Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Cross-reactivity00:42

Cross-reactivity

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interspecies assessment factors and skin sensitization risk assessment.

Regulatory toxicology and pharmacology : RTP·2018
Same author

Advice for patients with hair dye allergy remains 'stop using permanent hair dyes'.

The British journal of dermatology·2016
Same author

Skin sensitization: Implications for integration of clinical data into hazard identification and risk assessment.

Human & experimental toxicology·2015
Same author

T helper cell 2 immune skewing in pregnancy/early life: chemical exposure and the development of atopic disease and allergy.

The British journal of dermatology·2014
Same author

The hapten-atopy hypothesis III: the potential role of airborne chemicals.

The British journal of dermatology·2013
Same author

Non-animal approaches in skin toxicology.

Archives of toxicology·2012
Same journal

Improving Prognostication for Cutaneous Squamous Cell Carcinoma.

The British journal of dermatology·2026
Same journal

Recurrent and novel GLTP variants in five patients with nonsyndromic epidermal differentiation disorder: phenotypic and genotypic expansion.

The British journal of dermatology·2026
Same journal

Sustained efficacy of dupilumab in pediatric patients with moderate-to-severe atopic dermatitis over 1 year.

The British journal of dermatology·2026
Same journal

EPHX3-nEDD: from molecular diagnosis to epidermal lipid biology.

The British journal of dermatology·2026
Same journal

BAP1-tumour predisposition syndrome.

The British journal of dermatology·2026
Same journal

Comment on 'Incidence and Mortality of Mucous Membrane Pemphigoid in France': reply from authors.

The British journal of dermatology·2026
See all related articles

Related Experiment Video

Updated: May 14, 2026

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

Why does allergic contact dermatitis exist?

J P McFadden1, P Puangpet, D A Basketter

  • 1Department of Cutaneous Allergy, St John's Institute of Dermatology, St Thomas' Hospital, London SE1 7GN, UK. john.mcfadden@kcl.ac.uk

The British Journal of Dermatology
|February 7, 2013
PubMed
Summary
This summary is machine-generated.

Toll-like receptor (TLR)2 and TLR4 activation by danger-associated molecular patterns (DAMPs) drives allergic contact dermatitis (ACD) through cytokine signaling and immune circuits. This mechanism explains skin sensitization and may inform treatments for inflammatory skin diseases.

More Related Videos

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

Related Experiment Videos

Last Updated: May 14, 2026

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

Area of Science:

  • Immunodermatology
  • Molecular mechanisms of skin inflammation
  • Microbiome-host interactions

Background:

  • Allergic contact dermatitis (ACD) presents a paradox: the skin immune system reacts to harmless chemicals.
  • Toll-like receptors (TLRs), specifically TLR2 and TLR4, are implicated in ACD signaling pathways.
  • Extracellular danger-associated molecular patterns (DAMPs) activate TLRs, initiating inflammatory responses.

Purpose of the Study:

  • To investigate the role of TLR2 and TLR4 activation by DAMPs in allergic contact dermatitis (ACD).
  • To elucidate the cytokine signaling pathways and immune circuits involved in skin sensitization and inflammation.
  • To explore the connection between bacterial interactions, immune circuits, and inflammatory skin conditions.

Main Methods:

  • Analysis of TLR2 and TLR4 activation by extracellular DAMPs.
  • Assessment of cytokine expression (IL-1β, IL-6, IL-12, IL-18, IL-23, TNF-α, IFN-α) following TLR activation.
  • Investigation of CD4+ Th1 and Th17 cell recruitment and DAMP secretion.
  • Comparison of immune responses to pathogenic versus commensal bacteria.

Main Results:

  • TLR4/2 activation by DAMPs induces key cytokines that promote skin sensitization and allergy elicitation.
  • A positive-feedback loop (DAMP immune circuit) involving Th1 cells amplifies skin inflammation.
  • Pathogenic bacteria stimulate Th1/Th17-promoting cytokines via TLR2/4, creating a similar immune circuit.
  • The skin immune system distinguishes between pathogenic and commensal bacteria, utilizing shared pathways.

Conclusions:

  • TLR2 and TLR4 signaling, driven by DAMPs and amplified by immune circuits, is central to ACD pathogenesis.
  • These pathways offer insights into chronic inflammatory dermatoses like acne vulgaris.
  • Commensal bacteria-derived safety signals may represent therapeutic targets for inflammatory skin diseases.